Genome Biol:用于揭示阿尔兹海默氏症早期发病的基因特性

2015-09-10 佚名 生物谷

来自伦敦国王学院的科学家近日通过研究发现,一种用于特殊的基因特性或可帮助预测某些疾病的早期发病情况,比如阿尔兹海默氏症,相关研究刊登于国际杂志Genome Biology上。该研究中研究者旨在在65岁的老年个体机体中定义一些和健康老化相关的基因特性,而利用分子特性研究者常常可以进行年龄相关疾病早期风险的判断,这就可以帮助寻找指示疾病的新型指示器。 研究者James Timmons教授表示,我

来自伦敦国王学院的科学家近日通过研究发现,一种用于特殊的基因特性或可帮助预测某些疾病的早期发病情况,比如阿尔兹海默氏症,相关研究刊登于国际杂志Genome Biology上。该研究中研究者旨在在65岁的老年个体机体中定义一些和健康老化相关的基因特性,而利用分子特性研究者常常可以进行年龄相关疾病早期风险的判断,这就可以帮助寻找指示疾病的新型指示器。
研究者James Timmons教授表示,我们利用出生年份或实足年龄就可以个体是否享有医疗保险,而很多人都知道所有的60岁个体似乎并不都是可以得到保险的,本文研究中,研究人员首次阐明了人类机体生物学年龄的强大分子特性,而且还可以转变方法来使生物学年龄用来帮助进行医疗决策,这其中就包括鉴别出哪些个体更易患阿尔兹海默氏症,从而帮助提前制定治疗策略。

文章中,研究人员分析了65岁的健康老年个体机体中的RNA,并且利用相关信息发现了可以指示健康老化的150个RNA基因的特性,这些基因特性可以作为可靠的预测子来指示年龄相关的疾病;利用RNA的分子特性研究人员随后开发出了一种“健康年龄基因分值”以此来检测并且对比不同个体的RNA特性信息,而且分数越高往往和个体的健康程度越好直接相关。

随后研究者对70岁的老年个体机体的RNA信息进行分析,并且分析了这些个体在过去20年里的健康数据,尽管这些个体都是在同一年内出生的,但对其机体RNA信息进行分析却发现了个体的健康年龄基因分值出现了广泛分布的情况,或者出现了4倍范围的变化,这些改变或许就和个体的长期健康相关。

研究者指出,尤其对于患阿尔兹海默氏症的病人而言,其机体血液中的健康老化的RNA特性发生了变化,而且健康年龄的基因分值较低,Timmons教授表示,进行首次血液检测就可以帮助揭示血液及和痴呆症相关的大脑区域中相同类型的分子调节信息,这样就可以帮助进行痴呆症的预测,而大量研究证据显示,人类的痴呆症或许可以被称之为机体加速老化或健康老化程序激活失败的一种表现形式。

进行早期干预对于有效治疗阿尔兹海默氏症非常关键,而且研究者表示,健康老化的基因分值也可以同其它方法进行整合来帮助决定哪些中年个体应当早期进入临床的干预治疗阶段,从而有效预防中年个体早期阿尔兹海默氏症的表现。

原文出处:

Sanjana Sood12, Iain J. Gallagher13, et al.A novel multi-tissue RNA diagnostic of healthy ageing relates to cognitive health status.Genome Biol.2015

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1766962, encodeId=f0931e66962db, content=<a href='/topic/show?id=64f5343e2f' target=_blank style='color:#2F92EE;'>#Biol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3437, encryptionId=64f5343e2f, topicName=Biol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=446937890434, createdName=12498ebem31暂无昵称, createdTime=Fri May 13 01:59:00 CST 2016, time=2016-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2060911, encodeId=b8b320609116e, content=<a href='/topic/show?id=226841e943a' target=_blank style='color:#2F92EE;'>#基因特性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41794, encryptionId=226841e943a, topicName=基因特性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4723380, createdName=yangcx0915, createdTime=Sun Oct 25 03:59:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1917190, encodeId=9730191e1905a, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Wed Aug 17 08:59:00 CST 2016, time=2016-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1402663, encodeId=1807140266368, content=<a href='/topic/show?id=60ca9e761ce' target=_blank style='color:#2F92EE;'>#阿尔兹海默#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97761, encryptionId=60ca9e761ce, topicName=阿尔兹海默)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=be952422716, createdName=habb, createdTime=Fri Sep 11 23:59:00 CST 2015, time=2015-09-11, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1766962, encodeId=f0931e66962db, content=<a href='/topic/show?id=64f5343e2f' target=_blank style='color:#2F92EE;'>#Biol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3437, encryptionId=64f5343e2f, topicName=Biol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=446937890434, createdName=12498ebem31暂无昵称, createdTime=Fri May 13 01:59:00 CST 2016, time=2016-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2060911, encodeId=b8b320609116e, content=<a href='/topic/show?id=226841e943a' target=_blank style='color:#2F92EE;'>#基因特性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41794, encryptionId=226841e943a, topicName=基因特性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4723380, createdName=yangcx0915, createdTime=Sun Oct 25 03:59:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1917190, encodeId=9730191e1905a, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Wed Aug 17 08:59:00 CST 2016, time=2016-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1402663, encodeId=1807140266368, content=<a href='/topic/show?id=60ca9e761ce' target=_blank style='color:#2F92EE;'>#阿尔兹海默#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97761, encryptionId=60ca9e761ce, topicName=阿尔兹海默)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=be952422716, createdName=habb, createdTime=Fri Sep 11 23:59:00 CST 2015, time=2015-09-11, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1766962, encodeId=f0931e66962db, content=<a href='/topic/show?id=64f5343e2f' target=_blank style='color:#2F92EE;'>#Biol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3437, encryptionId=64f5343e2f, topicName=Biol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=446937890434, createdName=12498ebem31暂无昵称, createdTime=Fri May 13 01:59:00 CST 2016, time=2016-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2060911, encodeId=b8b320609116e, content=<a href='/topic/show?id=226841e943a' target=_blank style='color:#2F92EE;'>#基因特性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41794, encryptionId=226841e943a, topicName=基因特性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4723380, createdName=yangcx0915, createdTime=Sun Oct 25 03:59:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1917190, encodeId=9730191e1905a, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Wed Aug 17 08:59:00 CST 2016, time=2016-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1402663, encodeId=1807140266368, content=<a href='/topic/show?id=60ca9e761ce' target=_blank style='color:#2F92EE;'>#阿尔兹海默#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97761, encryptionId=60ca9e761ce, topicName=阿尔兹海默)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=be952422716, createdName=habb, createdTime=Fri Sep 11 23:59:00 CST 2015, time=2015-09-11, status=1, ipAttribution=)]
    2016-08-17 sunylz
  4. [GetPortalCommentsPageByObjectIdResponse(id=1766962, encodeId=f0931e66962db, content=<a href='/topic/show?id=64f5343e2f' target=_blank style='color:#2F92EE;'>#Biol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3437, encryptionId=64f5343e2f, topicName=Biol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=446937890434, createdName=12498ebem31暂无昵称, createdTime=Fri May 13 01:59:00 CST 2016, time=2016-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2060911, encodeId=b8b320609116e, content=<a href='/topic/show?id=226841e943a' target=_blank style='color:#2F92EE;'>#基因特性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41794, encryptionId=226841e943a, topicName=基因特性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4723380, createdName=yangcx0915, createdTime=Sun Oct 25 03:59:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1917190, encodeId=9730191e1905a, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Wed Aug 17 08:59:00 CST 2016, time=2016-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1402663, encodeId=1807140266368, content=<a href='/topic/show?id=60ca9e761ce' target=_blank style='color:#2F92EE;'>#阿尔兹海默#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97761, encryptionId=60ca9e761ce, topicName=阿尔兹海默)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=be952422716, createdName=habb, createdTime=Fri Sep 11 23:59:00 CST 2015, time=2015-09-11, status=1, ipAttribution=)]

相关资讯

10分钟检测阿尔兹海默病

对于如何研发快速、便宜的阿尔兹海默病检测仪器,科学家们仍束手无策。然而,一家纽约初创企业Cerebral 却找到了方法,开发出一种游戏机模样的工具——Cognivue,用于捕捉疾病早期症状。据华盛顿邮报介绍,Cognivue是一款认知评定工具,能够通过电脑发现阿尔兹海默的一些症状。病人坐在屏幕前,用鼠标追踪一系列清晰但不断移动的点。随着点不断运动,处于阿尔兹海默早期的病人会感到十分困难。这个仅需十

新型潜在分子或可用于检测生物老化

近日,Doug博士说:“鉴于早期干预的需要,许多当前治疗阿尔茨海默氏症的药物正在疾病的早期阶段被测试,甚至在症状开始之前就已经开始测试了。进一步的研究可以帮助我们发现新的治疗方法,让更容易患阿尔茨海默氏症的人来参与临床试验。”“先前的研究已经确定了阿尔茨海默氏症患者的血液标记,但他们在定期研究中或临床实验中尚未明确精确用量。本研究采用一种新颖的方法,用健康老年人来识别一种“健康老龄化”标记模式